Shares of McKesson Corp. MCK advanced 1.29% to $603.40 Monday, on what proved to be an all-around great trading session for ...

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Buying $100 In MCK: If an investor had bought $100 of MCK stock 20 years ago, it would be worth $1,621.13 today based on a ...

Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its ...

S&P Global Ratings has revised its outlook on McKesson Corp (NYSE:MCK). to positive from stable, while affirming its 'BBB+' ...

Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q4 CY2024, ...

Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being ...

The stock's fall snapped a three-day winning streak.

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

McKesson will purchase an 80% interest for approximately $850 million, while Prism Vision physicians will retain a 20% ...

Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors ...

Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...